Results 161 to 170 of about 242,673 (264)

Perioperative Factor Xa Inhibitor Discontinuation for Patients Undergoing Procedures With Minimal or Low Bleeding Risk.

JAMA Netw Open
Lee SR, Lee KY, Park JS, Lee YS, Oh YS, Han SJ, Namgung J, Lee JH, Lim WH, Ahn MS, Kwon S, Ahn HJ, Oh S, Lip GYH, Choi EK, PERIXa Investigators.   +15 more
europepmc   +1 more source

Heavy menstrual bleeding on direct factor Xa inhibitors: the MEDEA randomized clinical trial. [PDF]

Res Pract Thromb Haemost
Hamulyák EN, Wiegers HMG, Hutten BA, de Lange ME, Timmermans A, Westerweel PE, Nijziel MR, Klok FA, Hovens MM, Kamphuisen PW, Büller HR, Middeldorp S, Scheres LJJ.   +12 more
europepmc   +1 more source

Effectiveness and safety of antithrombin for treatment of portal vein thrombosis: Nationwide prospective surveillance of 4 years of clinical experience in Japan

Hepatology Research, EarlyView.
Abstract Aim Antithrombin (AT), a plasma protein with anticoagulant properties, has a long‐standing medical history, primarily for treatment of congenital AT deficiency. Accumulated clinical experiences suggest AT is a potential anticoagulant for thrombotic diseases. This study aimed to clarify the effectiveness, safety, and clinical significance of AT
Shoichi Matsutani, Makoto Arakawa, Susumu Nakano   +2 more
wiley   +1 more source

The impact of factor Xa inhibitors on bleeding risk in patients with respiratory diseases. [PDF]

Sci Rep
Hamada S, Muramoto K, Akaike K, Okabayashi H, Masunaga A, Tomita Y, Ichiyasu H, Sakagami T.   +7 more
europepmc   +1 more source

Impacts of Cr(III) and Cr(VI) concentrations on key high‐level waste glass properties

International Journal of Applied Glass Science, EarlyView.
Abstract This study investigates the effects of chromium concentration and redox on simulated high‐level waste (HLW) borosilicate glass properties for high‐chromium Hanford wastes. Thirty glasses with target 1 ≤ Cr2O3 ≤ 2.5 wt% were fabricated and analyzed.
Vivianaluxa Gervasio, Sarah A. Saslow, Jesse B. Lang, Bjorn E. Westman, Derek A. Cutforth, Suzanne M. Baird, Sulaiman E. Sannoh, Renee L. Russell, Jarrod V. Crum, AA Kruger, John D. Vienna   +10 more
wiley   +1 more source

Association of anti-factor Xa-guided anticoagulation with hemorrhage during ECMO support: A systematic review and meta-analysis. [PDF]

Clin Cardiol
Rajsic S, Breitkopf R, Treml B, Jadzic D, Innerhofer N, Eckhardt C, Oberleitner C, Bukumiric Z.   +7 more
europepmc   +1 more source

Measuring Direct Oral Anticoagulant (DOAC) Levels: Applications, Limitations, and Future Directions

International Journal of Laboratory Hematology, EarlyView.
ABSTRACT Introduction There are important challenges with the measurement and interpretation of direct oral anticoagulant (DOAC) anticoagulant effect including a lack of therapeutic ranges, inaccuracy of routinely available coagulation assays, lack of established thresholds for clinically significant effect, and uncertainty about how to apply the ...
Siraj Mithoowani, Chee Wee Tan, Deborah M. Siegal   +2 more
wiley   +1 more source

Letter to Dobesh et al. on lower mortality with andexanet alfa in factor Xa inhibitor-related major bleeding. [PDF]

Res Pract Thromb Haemost
Lucarelli S, Derry K, Atallah S, Stevens C.   +3 more
europepmc   +1 more source

Variability of Argatroban Effects on the Multiple APTT Reagents in High and Low Coagulation Activity Samples

International Journal of Laboratory Hematology, EarlyView.
ABSTRACT Introduction Argatroban is routinely monitored using activated partial thromboplastin time (APTT), with a recommended target range of 1.5–3.0 times. Although this range was established based on clinical trial data, including several APTT reagents, the differences in reactivity among APTT reagents remain unclear.
Osamu Kumano, Masahiro Ieko, Teruto Hashiguchi, Takashi Ito, Satoshi Yamazaki, Sumiyoshi Naito, Masako Yamazaki   +6 more
wiley   +1 more source

Direct Optical Detection of Factor Xa Activity in Minimally Processed Whole Blood

Cartwright AP, Wollant BC, York ES, Zheng L, Yee S, Chau HC, Batsuli G, Soh HT.   +7 more
europepmc   +1 more source